AUG 04, 2019 7:20 AM PDT

Understanding TP53's role in cancer

New research published in the journal Cell Reports sheds light on the role of the TP53 gene in preventing the spread of cancer. The TP53 gene codes tumor protein p53, a tumor suppressor that stops cells from dividing and proliferating too fast. Because of this important capability, many previous studies have looked into the role that TP53 plays in cancer; however, this study is the largest to date, incorporating over 10,000 cancer patients and 32 different kinds of cancer. The research was led by Dr. Larry Donehower, a professor of molecular virology and microbiology at the Baylor College of Medicine in Houston, TX.

Using data from The Cancer Genome Atlas (TCGA), the researchers Dr. Donehower and his colleagues were able to identify four genes that show overexpression in mutant TP53 tumors. They linked these four genes to a patient’s prognosis. Dr. Donehower explains:

"If you have a high expression of those four genes, you have a patient who's more likely to have a bad prognosis [...] Conversely, if that patient has a very low expression of those genes, (s)he's probably going to survive longer and have a good prognosis. It will give you a better picture of how (s)he'll fare than just knowing whether (s)he's mutant for TP53 or not.”

But that’s not the only finding from this study: the researchers also concluded that TP53 mutations are associated with genetic instability and occur more frequently in patients with a poorer outlook. They also determined that over 91% of cancers with TP53 mutations also exhibit the “loss of both functional TP53 alleles," or gene variants. These discoveries are significant to widening the scientific community’s understanding of TP53 and its role in cancer.

New research illuminates the role of TP53 in cancer. Photo: Pixabay

The distinction with this study, says Dr. Donehower, was its breadth. "Most studies on TP53focus on one cancer type. Looking at 32 different cancer types, you see that certain patterns hold up regardless of cancer type."

Co-author David Wheeler agrees, elaborating that their findings could help develop more treatments. "Since TP53 is one of the most important gatekeepers in cancer prevention, the better we understand this gene, the better able we will be to understand the basic biology of cancer. That will lead to better therapies."

Sources: Medical News Today, Cell Reports

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 04, 2020
Cancer
APR 04, 2020
Unique Cancer Mutation Hijacks Nearby Signaling Pathway
  In cancer, tyrosine kinase mutations are quite common. MET is one such example that normally binds its native lig ...
MAR 31, 2020
Cancer
MAR 31, 2020
Ovarian cancer metastasis and CPT1A
Research published in the journal Molecular Cancer Research from collaborators at the University of Colorado C ...
APR 09, 2020
Cancer
APR 09, 2020
Adjuvant immunotherapy proves effective for colon cancer
Results from a study published in Nature Medicine highlights the benefits of receiving pre-surgery immunotherapy for som ...
MAY 12, 2020
Clinical & Molecular DX
MAY 12, 2020
Could Catching the Flu Be Linked to an Increased Cancer Risk?
Results from a new research study suggest that a spike in infections such as influenza could be linked to the risk of de ...
MAY 18, 2020
Cancer
MAY 18, 2020
The threat of climate change extends to cancer progression
A study appearing in the American Cancer Society’s CA: A Cancer Journal for Clinicians argues that climate change ...
MAY 22, 2020
Cancer
MAY 22, 2020
Even minimal exercise can reduce breast cancer recurrence
New research urges individuals at high-risk of breast cancer to get moving, shaking, shimmying, and kicking! According t ...
Loading Comments...